Dirk Brockstedt
Directeur Technique/Scientifique/R&D chez RAPT THERAPEUTICS, INC.
Fortune : 216 996 $ au 30/04/2024
Postes actifs de Dirk Brockstedt
Sociétés | Poste | Début | Fin |
---|---|---|---|
RAPT THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/06/2019 | - |
ShangPharma Innovation, Inc.
ShangPharma Innovation, Inc. Investment ManagersFinance ShangPharma Innovation Inc. (ShangPharma Innovation) is a venture capital firm, a subsidiary of Shangpharma Investment Group Ltd. founded in 2016. The firm is headquartered in San Francisco, California. | Consultant / Advisor | - | - |
Historique de carrière de Dirk Brockstedt
Anciens postes connus de Dirk Brockstedt
Sociétés | Poste | Début | Fin |
---|---|---|---|
CHINOOK THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/04/2009 | 01/12/2017 |
Anza Therapeutics, Inc.
Anza Therapeutics, Inc. Medical SpecialtiesHealth Technology Anza Therapeutics, Inc. develops products in the fields of cancer and infectious diseases. It also develops immunotherapy for infectious diseases, therapeutic vaccines for treating cancers that over-express Mesothelin and for treating people infected with the hepatitis C virus (HCV). The company was founded in 2007 and is headquartered in Concord, CA. | Directeur Technique/Scientifique/R&D | 01/01/2007 | 01/01/2009 |
CERUS CORPORATION | Corporate Officer/Principal | 01/01/2002 | 01/01/2007 |
Aventis, Inc. | Corporate Officer/Principal | - | - |
Formation de Dirk Brockstedt
University of Kiel | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 7 |
Allemagne | 2 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 3 |
Corporate Officer/Principal | 2 |
Doctorate Degree | 1 |
Sectorielle
Health Technology | 5 |
Consumer Services | 2 |
Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
CERUS CORPORATION | Health Technology |
RAPT THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 4 |
---|---|
Aduro BioTech, Inc.
Aduro BioTech, Inc. Pharmaceuticals: MajorHealth Technology Aduro BioTech, Inc. is a clinical-stage immunotherapy company, which engages in the discovery, development, and commercialization of therapies that transform the treatment of diseases, including cancer. Its technology platforms include STING Pathway Activator, B-select monoclonal antibody, and LADD, or Live, Attenuated, Double-Deleted Listeria monocytogenes. The company's platforms stimulate and/or regulate innate and adaptive immune responses, either as single agents or in combination with conventional therapies like chemotherapy and radiation as well as other novel immunotherapies. Aduro BioTech was founded in 2000 and is headquartered in Berkeley, CA. | Health Technology |
Aventis, Inc. | |
Anza Therapeutics, Inc.
Anza Therapeutics, Inc. Medical SpecialtiesHealth Technology Anza Therapeutics, Inc. develops products in the fields of cancer and infectious diseases. It also develops immunotherapy for infectious diseases, therapeutic vaccines for treating cancers that over-express Mesothelin and for treating people infected with the hepatitis C virus (HCV). The company was founded in 2007 and is headquartered in Concord, CA. | Health Technology |
ShangPharma Innovation, Inc.
ShangPharma Innovation, Inc. Investment ManagersFinance ShangPharma Innovation Inc. (ShangPharma Innovation) is a venture capital firm, a subsidiary of Shangpharma Investment Group Ltd. founded in 2016. The firm is headquartered in San Francisco, California. | Finance |
- Bourse
- Insiders
- Dirk Brockstedt
- Expérience